European Markets Slide Amid Rising Oil and Inflation Concerns
European shares experienced a decline on Monday as oil prices surged in the wake of renewed hostilities between…
European Markets Brace for Impact Amid Rising Oil Prices and Political Shifts
European markets showed little movement on Monday as oil prices soared following recent U.S.-Iran conflicts, fueling inflation concerns…
Switzerland-Based Novartis Breaks Ground on Radioligand Therapy Site in Denton » Dallas Innovates
Novartis breaks ground on its Denton radioligand therapy site. [Photo: Novartis] Swiss global pharmaceutical giant Novartis recently broke…
Novartis partners with Special Olympics World Winter Games Switzerland 2029
Novartis is proud to be an official partner of the Special Olympics World Winter Games Switzerland 2029, which…
Protected Witnesses Found Guilty in Greece’s Novartis Trial
Two formerly protected witnesses at the center of Greece’s high-profile Novartis case were found guilty on Tuesday by…
Δίκη Novartis: Ενοχή και για τους δύο πρώην προστατευόμενους μάρτυρες
Με τη λέξη «ενοχή» σφράγισε την αγόρευση της η εισαγγελέας του Τριμελούς Πλημμελειοδικείου της Αθήνας ενώπιον του οποίου…
Switzerland’s Novartis buying San Diego biotech Avidity in $12 billion cash deal
Novartis staff celebrate the company’s 25 years in San Diego outside the Genomics Institute of the Novartis Research…
Glomerulonephritis Market Projected to Surge by 2034 with Rising Demand for Targeted Therapies
The glomerulonephritis market is witnessing steady growth driven by the increasing prevalence of chronic kidney diseases and improved…
Swiss drugmaker Novartis says it can withstand potential tariffs; TikTok deal reached as US and China seek to break trade deadlock
The CEO of Swiss pharmaceutical company Novartis said Saturday that it has enough stockpiles in the US to…
Swiss drugmaker Novartis says it can withstand potential tariffs; TikTok deal reached as US and China seek to break trade deadlock
The CEO of Swiss pharmaceutical company Novartis said Saturday that it has enough stockpiles in the US to…
Europe’s STOXX 600 slips as French rating review looms; still ends week higher
European shares ended the week on a strong note but were a little lower on Friday as investors…
Novartis to acquire Tourmaline Bio, complementing cardiovascular pipeline with pacibekitug for the treatment of atherosclerotic cardiovascular disease (ASCVD)
Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for…